Monday, November 30, 2015 10:36:48 AM
In October 2014 the Medicare Hospital-Acquired Condition (HAC) Reduction Program began penalizing poor performing hospitals for their rates of three “preventable conditions”, for which Covalon (and it's partners) have already targeted with novel infection control products that are currently on the market. The three equally weighted categories: rates of Central Line-Associated Bloodstream Infections (CLABSIs), rates of Catheter-Associated Urinary Tract Infections (CAUTIs), and other "serious complications" which includes eight types of serious but preventable complications. The criteria will expand in 2015 to include Surgical Site Infections (SSIs) and in 2016 will expand to include incident rates of two antibiotic resistant bacteria: Clostridium difficile and Methicillin-resistant Staphylococcus aureus (MRSA) [1]. Covalon currently has both licensed products and Covalon branded products that are clinically proven to provide superior performance in addressing CLABSIs (IV Clear), CAUTIs (SilverCoat Foley Catheters [Medline Silvertouch Foley Catheters]), and SSIs (SurgiClear).
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM